Skip to content

Public FDA record

Z-0527-2013: EBI XFIX DFS Rail System (Adult Rail Gradual Swivel Clamp). The Biomet Rail System consists of a unilater

Recall record Z-0527-2013 for Biomet, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0527-2013
Company in FDA record
Biomet, Inc.
FDA classification date
Dec 17, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

It was reported that the number scale/graduation markings were missing on 14 pieces of the swivel clamp.

Source facts

Action
On 11/9/2012 an URGENT MEDICAL DEVICE RECALL NOTIFICATION letter was sent to all consignees (distributors and Doctor notices) informing them of the issue and providing recommended actions. Customer contact number (574) 372-1570 Monday through Friday from 8 am to 5 pm.
Initiated
2012-11-09
Root cause
Process design
Terminated
2013-08-28
Distribution
Worldwide Distribution, including the states of TX, TN, PA, CA, NY, FL, and MI and the countries of Japan and Columbia.
Recall number
Z-0527-2013
Recall status
Terminated
CDRH record ID
114639
FDA classified
2012-12-17
Recall event number
63725

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗